CN Patent
CN102311395B — 喹唑啉环取代的二苯脲类衍生物及其用途
Assigned to Individual · Expires 2014-04-16 · 12y expired
What this patent protects
本发明公开了一种喹唑啉环取代的二苯脲类衍生物及其用途,喹唑啉环取代的二苯脲类衍生物具体如式【I】结构,其中,R 1 为氢、氨基、丙烯酰氨基、直链烷氧烷氧基或直链吗啉代基烷氧基;R 2 为直链烷氧烷氧基或直链吗啉代基烷氧基;R 3 为卤素。本发明可应用于治疗肿瘤或白血病应用。
USPTO Abstract
本发明公开了一种喹唑啉环取代的二苯脲类衍生物及其用途,喹唑啉环取代的二苯脲类衍生物具体如式【I】结构,其中,R 1 为氢、氨基、丙烯酰氨基、直链烷氧烷氧基或直链吗啉代基烷氧基;R 2 为直链烷氧烷氧基或直链吗啉代基烷氧基;R 3 为卤素。本发明可应用于治疗肿瘤或白血病应用。
Drugs covered by this patent
- Lotemax (LOTEPREDNOL ETABONATE) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.